Acute Lymphoblastic Leukemia (ALL)

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphoblastic Leukemia (ALL) Trial in United States (Vincristine Sulfate Liposomes Injection (VSLI), Vincristine Sulfate

Terminated
  • Acute Lymphoblastic Leukemia (ALL)
  • Vincristine Sulfate Liposomes Injection (VSLI)
  • Vincristine Sulfate Injection (VSI)
  • La Jolla, California
  • +14 more
Sep 6, 2021

Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Marqibo® (vincristine sulfate liposomes injection))

Completed
  • Acute Lymphoblastic Leukemia (ALL)
  • Marqibo® (vincristine sulfate liposomes injection)
  • Los Angeles, California
  • +32 more
Feb 8, 2021

Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

Active, not recruiting
  • Hematological Malignancies
  • +6 more
  • NiCord® (omidubicel)
  • Cord Blood Unit
  • Los Angeles, California
  • +51 more
Jan 7, 2021

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States

Withdrawn
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Los Angeles, California
  • +4 more
Mar 12, 2018

For Donors, Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling, For Recipients Trial in United States

Terminated
  • For Donors
  • +9 more
  • Los Angeles, California
  • +7 more
Apr 6, 2017

Acute Lymphoblastic Leukemia (ALL) Trial in United States (Moxetumomab Pasudotox)

Terminated
  • Acute Lymphoblastic Leukemia (ALL)
  • Moxetumomab Pasudotox
  • Los Angeles, California
  • +3 more
Sep 15, 2015